Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 9/20 | 0.42 |
| ▸ | AR | P10275 | 8/20 | 0.39 |
| ▸ | NPC1 | O15118 | 4/20 | 0.34 |
| ▸ | RAB9A | P51151 | 4/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL15231133 | 0.82 | FAAH (0.43) | FAAHARNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL2268188 | 0.80 | FAAH (0.48) | FAAH | |
| SCHEMBL2222334 | 0.80 | FAAH (0.36) | FAAHAR | |
| SCHEMBL2270790 | 0.77 | FAAH (0.42) | FAAHARNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL2270795 | 0.77 | FAAH (0.41) | FAAHARNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL15230250 | 0.77 | FAAH (0.36) | FAAHNPC1RAB9A | |
| SCHEMBL15231196 | 0.75 | FAAH (0.45) | FAAHARNPC1RAB9ASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL15231194 | 0.74 | FAAH (0.44) | FAAHARNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL193616 | 0.74 | FAAH (0.46) | FAAH | |
| Ammonia Solution, Strong SCHEMBL20798400 | 0.73 | FAAH (0.45) | FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2521450-B1 | FUNGICIDAL HETEROCYCLIC COMPOUNDS | DU PONT (US) | 2015-02-25 | — | — | EP | disclosed |
| US-8835427-B2 | Fungicidal heterocyclic compounds | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-09-16 | — | — | US | disclosed |
| US-20120309752-A1 | FUNGICIDAL HETEROCYCLIC COMPOUNDS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-12-06 | — | — | US | disclosed |
| EP-2521450-A1 | FUNGICIDAL HETEROCYCLIC COMPOUNDS | E.I. Du Pont De Nemours And Company (US) | 2012-11-14 | — | — | EP | disclosed |
| WO-2011085170-A1 | FUNGICIDAL HETEROCYCLIC COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-07-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120309752-A1 | FUNGICIDAL HETEROCYCLIC COMPOUNDS | CYP1B1, NOX3, CYP1A1 | FAAH 2751/4885AR 3747/4885NPC1 649/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.